Education & Training

Medical School

University of California at Irvine


Obstetrics & Gynecology

  • University of California Irvine Medical Center


Gynecologic Oncology

  • University of California Irvine Medical Center


American Board of Obstetrics & Gynecology
American Board of Obstetrics & Gynecology-Gynecologic Oncology

Commercial Relationships and Collaborations

This faculty member or a member of his or her immediate family has a working relationship, such as providing consulting, research, or educational services, with the companies listed below. These relationships have been reported to the University of Missouri and, if appropriate, plans have been established to address potential conflicts. The following relationships were reported as of July 2020.

Clovis Oncology

Hunter Biomedical Group, LLC.


MU Health Care participates with most major managed care organizations. To find out whether MU Health Care is a participating provider in your insurance plan or network, or for information on co-payments and deductibles, please contact your insurance carrier directly.

In the News

Focus On Your Health: Mark Hunter, MD, on the Power of Nutrition
Dr. Hunter Discusses FDA Decision to Expand HPV Vaccine Age Range

Academic Information

Associate Professor of Clinical Obstetrics and Gynecology
Director, Division of Gynecologic Oncology


404 N Keene St
Columbia, MO 65201
United States

P. 573-882-1057

Research Profile

Hunter specializes in gynecologic oncology. With nearly twenty years in practice, he has expertise in the diagnosis and treatment of ovarian, uterine, cervical, vaginal and vulvar cancers.

In addition to his clinical practice, Hunter also works to advance medical technology. Many women who develop uterine cancer require a hysterectomy, a removal of the uterus. Traditionally, the surgery leaves a large scar and results in several weeks’ recovery time. Hunter has developed a prototype surgical device that would allow hysterectomies to be performed less invasively.

Hunter has also been an early adopter of new medical innovations. For many of his cancer patients, he operates using the da Vinci Surgical System. This advanced device decreases incision size and reduces complications — in many cases, enabling the patient to go home the same day.

Dr. Mark Hunter is an assistant professor in the School of Medicine and a gynecologic oncology specialist with MU Health. He also serves as director of gynecologic oncology at MU’s Ellis Fischel Cancer Center.

Download the Featured Profile



Research Interests

  • Surgical and Medical Treatment of Gynecologic Cancers
  • Ovarian Cancer
  • Uterine Cancer
  • Cervical Cancer
  • Vaginal Cancer
  • Vulvar Cancer